Human subjects protection issues in QUERI implementation research: QUERI Series

Edmund Chaney, Laura G Rabuck, Jane Uman, Deborah C Mittman, Carol Simons, Barbara F Simon, Mona Ritchie, Marisue Cody, Lisa V Rubenstein, Edmund Chaney, Laura G Rabuck, Jane Uman, Deborah C Mittman, Carol Simons, Barbara F Simon, Mona Ritchie, Marisue Cody, Lisa V Rubenstein

Abstract

Background: Human Subjects protections approaches, specifically those relating to research review board oversight, vary throughout the world. While all are designed to protect participants involved in research, the structure and specifics of these institutional review boards (IRBs) can and do differ. This variation affects all types of research, particularly implementation research.

Methods: In 2001, we began a series of inter-related studies on implementing evidence-based collaborative care for depression in Veterans Health Administration primary care. We have submitted more than 100 IRB applications, amendments, and renewals, and in doing so, we have interacted with 13 VA and University IRBs across the United States (U.S.). We present four overarching IRB-related themes encountered throughout the implementation of our projects, and within each theme, identify key challenges and suggest approaches that have proved useful. Where applicable, we showcase process aids developed to assist in resolving a particular IRB challenge.

Results: There are issues unique to implementation research, as this type of research may not fit within the traditional Human Subjects paradigm used to assess clinical trials. Risks in implementation research are generally related to breaches of confidentiality, rather than health risks associated with traditional clinical trials. The implementation-specific challenges discussed are: external validity considerations, Plan-Do-Study-Act cycles, risk-benefit issues, the multiple roles of researchers and subjects, and system-level unit of analysis.

Discussion: Specific aspects of implementation research interact with variations in knowledge, procedures, and regulatory interpretations across IRBs to affect the implementation and study of best methods to increase evidence-based practice. Through lack of unambiguous guidelines and local liability concerns, IRBs are often at risk of applying both variable and inappropriate or unnecessary standards to implementation research that are not consistent with the spirit of the Belmont Report (a summary of basic ethical principles identified by the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research), and which impede the conduct of evidence-based quality improvement research. While there are promising developments in the IRB community, it is incumbent upon implementation researchers to interact with IRBs in a manner that assists appropriate risk-benefit determinations and helps prevent the process from having a negative impact on efforts to reduce the lag in implementing best practices.

References

    1. Fitzgerald MH, Phillips PA. Centralized and non-centralized ethics review: a five nation study. Account Res. 2006;13:47–74.
    1. Greene SM. Alternative Models of IRB Review for Multi-center Studies: The Evidence Base & On-the-Ground Implications. Group Health Center for Health Studies Colloquium. 2007.
    1. Rubenstein LV, Mittman BS, Yano EM, Mulrow CD. From understanding health care provider behavior to improving health care: the QUERI framework for quality improvement. Quality Enhancement Research Initiative. MedCare. 2000;38:I129–I141.
    1. Stetler CB, Legro MW, Rycroft-Malone J, Bowman C, Curran G, Guihan M, Hagedorn H, Pineros S, Wallace CM. Role of "external facilitation" in implementation of research findings: a qualitative evaluation of facilitation experiences in the Veterans Health Administration. Implement Sci. 2006;1:23. doi: 10.1186/1748-5908-1-23.
    1. Bellin E, Dubler NN. The quality improvement-research divide and the need for external oversight. Am J Public Health. 2001;91:1512–1517.
    1. Daly BJ, Rosenfeld K. Maximizing benefits and minimizing risks in health services research near the end of life. J Pain Symptom Manage. 2003;25:S33–42. doi: 10.1016/S0885-3924(03)00059-9.
    1. Greene SM, Geiger AM, Harris EL, Altschuler A, Nekhlyudov L, Barton MB, Rolnick SJ, Elmore JG, Fletcher S. Impact of IRB requirements on a multicenter survey of prophylactic mastectomy outcomes. Ann Epidemiol. 2006;16:275–278. doi: 10.1016/j.annepidem.2005.02.016. Epub 2005 Jul 2006.
    1. Christian MC, Goldberg JL, Killen J, Abrams JS, McCabe MS, Mauer JK, Wittes RE. A central institutional review board for multi-institutional trials. N Engl J Med. 2002;346:1405–1408. doi: 10.1056/NEJM200205023461814.
    1. Baily M, Bottrell M, Lynn J, Jennings B. The Ethics of Using QI Methods to Improve Health Care Quality and Safety. Garrision, NY; 2006. pp. S1–S39.
    1. Lo B, Groman M. Oversight of quality improvement: focusing on benefits and risks. Arch Intern Med. 2003;163:1481–1486. doi: 10.1001/archinte.163.12.1481.
    1. McWilliams R, Hoover-Fong J, Hamosh A, Beck S, Beaty T, Cutting G. Problematic variation in local institutional review of a multicenter genetic epidemiology study. Jama. 2003;290:360–366. doi: 10.1001/jama.290.3.360.
    1. Burman WJ, Reves RR, Cohn DL, Schooley RT. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med. 2001;134:152–157.
    1. Silverman H, Hull SC, Sugarman J. Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med. 2001;29:235–241. doi: 10.1097/00003246-200102000-00002.
    1. Department of Health and Human Services Institutional Review Boards: A Time for Reform. 1998. pp. 1–90.
    1. Shen JJ, Samson LF, Washington EL, Johnson P, Edwards C, Malone A. Barriers of HIPAA regulation to implementation of health services research. J Med Syst. 2006;30:65–69. doi: 10.1007/s10916-006-7406-z.
    1. Stair TO, Reed CR, Radeos MS, Koski G, Camargo CA. Variation in institutional review board responses to a standard protocol for a multicenter clinical trial. Acad Emerg Med. 2001;8:636–641. doi: 10.1111/j.1553-2712.2001.tb00177.x.
    1. Greene SM, Geiger AM. A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval. J Clin Epidemiol. 2006;59:784–790. doi: 10.1016/j.jclinepi.2005.11.018.
    1. Tod AM, Nicolson P, Allmark P. Ethical review of health service research in the UK: implications for nursing. J Adv Nurs. 2002;40:379–386. doi: 10.1046/j.1365-2648.2002.02385.x.
    1. Cassell J, Young A. Why we should not seek individual informed consent for participation in health services research. J Med Ethics. 2002;28:313–317. doi: 10.1136/jme.28.5.313.
    1. Green LA, Lowery JC, Kowalski CP, Wyszewianski L. Impact of institutional review board practice variation on observational health services research. Health Serv Res. 2006;41:214–230. doi: 10.1111/j.1475-6773.2005.00458.x.
    1. McQueen L, Mittman BS, Demakis JG. Overview of the Veterans Health Administration (VHA) Quality Enhancement Research Initiative (QUERI) J Am Med Inform Assoc. 2004;11:339–343. doi: 10.1197/jamia.M1499.
    1. Demakis JG, McQueen L, Kizer KW, Feussner JR. Quality Enhancement Research Initiative (QUERI): A collaboration between research and clinical practice. Med Care. 2000;38:I17–25. doi: 10.1097/00005650-200006001-00003.
    1. Stetler CB, Mittman BS, Francis J. Overview of the VA Quality Enhancement Research Initiative (QUERI) and QUERI theme articles: QUERI Series. Implementation Science. 2008;3:8. doi: 10.1186/1748-5908-3-8.
    1. Grol R, Jones R. Twenty years of implementation research. Fam Pract. 2000;17:S32–35. doi: 10.1093/fampra/17.suppl_1.S32.
    1. Stetler CB. Updating the Stetler Model of research utilization to facilitate evidence-based practice. Nurs Outlook. 2001;49:272–279. doi: 10.1067/mno.2001.120517.
    1. Stetler CB. Refinement of the Stetler/Marram model for application of research findings to practice. Nurs Outlook. 1994;42:15–25. doi: 10.1016/0029-6554(94)90067-1.
    1. Glasgow RE, McKay HG, Piette JD, Reynolds KD. The RE-AIM framework for evaluating interventions: what can it tell us about approaches to chronic illness management? Patient Educ Couns. 2001;44:119–127. doi: 10.1016/S0738-3991(00)00186-5.
    1. Green LW, Glasgow RE. Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology. Eval Health Prof. 2006;29:126–153. doi: 10.1177/0163278705284445.
    1. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999;89:1322–1327.
    1. Institute for Healthcare Improvement TestingChanges
    1. Lomas J. Using research to inform healthcare managers' and policy makers' questions: from summative to interpretive synthesis. Healthcare Policy. 2005;1:55–71.
    1. Institute for Healthcare Improvement . IHI collaborative model for achieving breakthrough improvement. Boston, MA; 2003. pp. 1–20.
    1. Alternative Models of IRB Review – Workshop Summary Report
    1. Alternative IRB Models: Optimizing Human Subject Protection – Conference Summary Report

Source: PubMed

3
Předplatit